{
    "2019-08-09": [
        [
            {
                "time": "2018-07-25",
                "original_text": "Nektar (NKTR) Q2 Earnings Beat Estimates, Revenues Miss",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Beat",
                        "Estimates",
                        "Revenues",
                        "Miss"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Intrexon (XON) Reports Narrower-Than-Expected Loss in Q2",
                "features": {
                    "keywords": [
                        "Narrower-Than-Expected",
                        "Loss",
                        "Q2"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-27",
                "original_text": "U.S. Court of Appeals Rules in Favor of Lilly in Alimta Alternate Salt Form Patent Lawsuit",
                "features": {
                    "keywords": [
                        "Court",
                        "Appeals",
                        "Rules",
                        "Favor",
                        "Lilly",
                        "Alimta",
                        "Patent",
                        "Lawsuit"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-28",
                "original_text": "Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "AGN",
                        "NVO",
                        "Earnings",
                        "EU",
                        "Nod",
                        "SNY",
                        "ABBV",
                        "Drugs",
                        "New",
                        "Patients"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-29",
                "original_text": "Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates",
                "features": {
                    "keywords": [
                        "Novo",
                        "Nordisk",
                        "Q2",
                        "Earnings",
                        "Revenues",
                        "Beat",
                        "Estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}